Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement

Salmaan Kanji,Meghan Hayes,Adam Ling,Larissa Shamseer,Clarence Chant,David J. Edwards,Scott Edwards,Mary H. H. Ensom,David R. Foster,Brian Hardy,Tyree H. Kiser,Charles la Porte,Jason A. Roberts,Rob Shulman,Scott Walker,Sheryl Zelenitsky,David Moher

DOI: https://doi.org/10.1007/s40262-015-0236-8

2015-01-31

Clinical Pharmacokinetics

Abstract:Background and ObjectiveTransparent reporting of all research is essential for assessing the validity of any study. Reporting guidelines are available and endorsed for many types of research but are lacking for clinical pharmacokinetic studies. Such tools promote the consistent reporting of a minimal set of information for end users, and facilitate knowledge translation of research. The objective of this study was to create a guideline to assist in the transparent and complete reporting of clinical pharmacokinetic studies.MethodsPreliminary content to be considered was identified from a systematic search of the literature and regulatory documents. Stakeholders were identified to participate in a modified Delphi exercise and a virtual meeting to generate consensus for items considered essential in the reporting of clinical pharmacokinetic studies. The proposed checklist was pilot tested on 100 recently published clinical pharmacokinetic studies. Overall and itemized compliance with the proposed guidance was determined for each study.ResultsSixty-eight stakeholders from nine countries consented to participate. Four rounds of a modified Delphi survey and a series of small virtual meetings were required to generate consensus for a 24-item checklist considered to be essential to the reporting of clinical pharmacokinetic studies. When applied to the 100 most recently published clinical pharmacokinetic studies, 45 were determined to be compliant with at least 80 % of the checklist items. Explanatory text was prepared using examples of compliant reporting from these and other relevant studies.ConclusionsThe reader’s ability to judge the validity of pharmacokinetic research can be greatly compromised by the incomplete reporting of study information. Using consensus methods, we have developed a tool to guide transparent and accurate reporting of clinical pharmacokinetic studies. Endorsement and implementation of these guidelines by researchers, clinicians and journals would promote more consistent reporting of these studies and allow for better assessment of utility for clinical applications.

pharmacology & pharmacy